Platelet Activation in Chronic Inflammatory Skin Diseases
NCT01759693 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2013-01-03
Summary
Platelets are blood cells that are important in coagulation of the blood. These cells have recently been shown to play a role in a number of other biologic processes, for example inflammation. In this study the investigators will determine the extent of platelet activation in people suffering from common chronic skin inflammation-urticaria and allergic dermatitis.
Conditions
- Urticaria
- Atopic Dermatitis
Interventions
- PROCEDURE
-
Blood sampling
Blood sampling
Sponsors & Collaborators
-
Meir Medical Center
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-02-28
- Primary Completion
- 2013-08-31
- Completion
- 2013-10-31
Countries
- Israel
Study Locations
More Related Trials
-
Dupilumab for the Treatment of Chronic Inducible Cold Urticaria in Patients Who Remain Symptomatic Despite the Use of H1-antihistamine (LIBERTY-CINDU CUrIADS)
NCT04681729 ·Status: COMPLETED ·Phase: PHASE3
-
Prospective Double-blind Placebo-controlled Study of the Effect of Xolair (Omalizumab) in Chronic Urticaria Patients
NCT01803763 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Omalizumab (Xolair) on Basophils in Patients With Chronic Idiopathic Urticaria
NCT01701583 ·Status: COMPLETED ·Phase: PHASE4
-
Phenotypic and Functional Characterisation of Human B-cell Response in Pemphigus
NCT04117529 ·Status: UNKNOWN ·Phase: NA
-
Phase 2a, Exploratory Study to Evaluate the Safety, Efficacy, Tolerability and Pharmacokinetics of XPF-002 in Patients With Primary/Inherited Erythromelalgia
NCT01486446 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of Loratadine for Prevention of Pegfilgrastim-Induced Pain
NCT01311336 ·Status: UNKNOWN ·Phase: PHASE2
-
Role of Circulating Innate Lymphoid Cells in Allergic Disorders
NCT03069495 ·Status: TERMINATED
-
Study of XPF-001 in the Treatment of Pain From Primary/Inherited Erythromelalgia (IEM)
NCT01090622 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Evaluate the Efficacy, Safety, and Tolerability of Tirabrutinib in Participants With Antihistamine-Resistant Chronic Spontaneous Urticaria
NCT04827589 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study of Mast Cell Precursors
NCT00001756 ·Status: COMPLETED
-
Urticaria Facticia Treatment With Omalizumab (UFO)
NCT02169115 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Omalizumab in Chronic Idiopathic Urticaria
NCT02166151 ·Status: UNKNOWN ·Phase: PHASE3
-
Comparative Analysis of the Th17 Cellular Response in Active and Inactive Pemphigus Vulgaris Patients
NCT04096222 ·Status: UNKNOWN
-
Cold Urticaria Treatment With Xolair
NCT01580592 ·Status: COMPLETED ·Phase: PHASE2
-
Use of Infliximab for the Treatment of Pemphigus Vulgaris
NCT00283712 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of MTPS9579A in Participants With Refractory Chronic Spontaneous Urticaria
NCT05129423 ·Status: WITHDRAWN ·Phase: PHASE2
-
Safety and Efficacy of Abatacept in Subjects With Chronic Urticaria Who Have Had an Inadequate Response to Anti-histamine Therapy
NCT00886795 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Elimination of Cardiac and Inflammatory Biomarkers and Adipokines by Therapeutic Plasma Exchange
NCT02533596 ·Status: COMPLETED
-
A Single and Multiple Ascending Dose Trial of LT-002-158 Tablets in Healthy Adult Volunteers
NCT06082323 ·Status: RECRUITING ·Phase: PHASE1
-
Mode of Action Study of Omalizumab in Patients With Chronic Idiopathic Urticaria (CIU) Who Fail to Respond to Antihistamine Treatment
NCT01599637 ·Status: COMPLETED ·Phase: PHASE2
-
Immunoadsorption, Dexamethasone Pulse Therapy and Rituximab for Pemphigus
NCT00656656 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Frequency and of the Regulatory Function of Positive T Lymphocytes Dual CD4CD8aa (DP8a) Specific to a Bacteria of the Intestinal Microbiota (Faecalibacterium Prausnitzii) in Atopic Dermatitis, Asthma and Allergic Rhinitis
NCT02908360 ·Status: COMPLETED
-
Safety and Efficacy of Itacitinib in Combination With Corticosteroids for Treatment of Graft-Versus-Host Disease in Pediatric Subjects
NCT03721965 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Topical Ruxolitinib in Chronic Hand Dermatitis
NCT05293717 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Rituximab in the Treatment of Patients With Bullous Pemphigoid
NCT00286325 ·Status: COMPLETED ·Phase: PHASE1/PHASE2